207 related articles for article (PubMed ID: 29776389)
41. Multivariate analysis of the effectiveness of using antibody induction therapy according to the degree of HLA mismatches.
Bunnapradist S; Hong A; Lee B; Takemoto SK
Transplant Proc; 2005 Mar; 37(2):886-8. PubMed ID: 15848565
[TBL] [Abstract][Full Text] [Related]
42. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
[TBL] [Abstract][Full Text] [Related]
43. Recipient-related risk factors for graft failure and death in elderly kidney transplant recipients.
Lai X; Chen G; Qiu J; Wang C; Chen L
PLoS One; 2014; 9(11):e112938. PubMed ID: 25389964
[TBL] [Abstract][Full Text] [Related]
44. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
[TBL] [Abstract][Full Text] [Related]
45. Re-Examining Risk of Repeated HLA Mismatch in Kidney Transplantation.
Tinckam KJ; Rose C; Hariharan S; Gill J
J Am Soc Nephrol; 2016 Sep; 27(9):2833-41. PubMed ID: 26888475
[TBL] [Abstract][Full Text] [Related]
46. The effect of HLA mismatching on graft survival in living-donor kidney transplants: Catholic Medical Center, 1984 to 1993.
Yoon YS; Jin DC; Yang CW; Kim SY; Bang BK; Kim WI; Koh YB
Clin Transpl; 1993; ():275-83. PubMed ID: 7918161
[TBL] [Abstract][Full Text] [Related]
47. Effect of HLA Matching on Pediatric Renal Transplant Graft Survival in China.
Zhao H; Lai X; Lu J; Lin Y; Wang P; Zhu L; Wu L; Xiao Z; Wang Q; Tan J
Transplant Proc; 2017; 49(6):1291-1293. PubMed ID: 28735996
[TBL] [Abstract][Full Text] [Related]
48. The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
Persijn GG; D'Amaro J; De Lange P; Schreuder GM; Thorogood J; Zantvoort F; Van Rood JJ
Clin Transpl; 1988; ():237-48. PubMed ID: 3154476
[TBL] [Abstract][Full Text] [Related]
49. Minor H antigen matches and mismatches are equally distributed among recipients with or without complications after HLA identical sibling renal transplantation.
Dierselhuis MP; Spierings E; Drabbels J; Hendriks M; Alaez C; Alberú J; Alvarez MB; Burlingham W; Campos E; Christiaans M; Claas F; Fasano ME; Gerbase-Delima M; Gervais T; Gorodezky C; Larriba J; Lardy NM; Latinne D; Morales-Buenrostro LE; Moreno MJ; Oguz F; Opelz G; Sergeant R; Tambutti M; Teper S; Tilanus M; Turkmen A; Warrens AN; Weimar W; Goulmy E
Tissue Antigens; 2013 Nov; 82(5):312-6. PubMed ID: 24116658
[TBL] [Abstract][Full Text] [Related]
50. Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients.
Smedbråten J; Mjøen G; Hartmann A; Åsberg A; Rollag H; Mollnes TE; Sandvik L; Fagerland MW; Thiel S; Sagedal S
BMC Nephrol; 2016 Oct; 17(1):148. PubMed ID: 27760523
[TBL] [Abstract][Full Text] [Related]
51. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
[TBL] [Abstract][Full Text] [Related]
52. Human leukocyte antigen matching in heart transplantation: systematic review and meta-analysis.
Ansari D; Bućin D; Nilsson J
Transpl Int; 2014 Aug; 27(8):793-804. PubMed ID: 24725030
[TBL] [Abstract][Full Text] [Related]
53. Prediction of Three-Year Mortality After Deceased Donor Kidney Transplantation in Adults with Pre-Transplant Donor and Recipient Variables.
Schwager Y; Littbarski SA; Nolte A; Kaltenborn A; Emmanouilidis N; Kleine-Döpke D; Klempnauer J; Schrem H
Ann Transplant; 2019 May; 24():273-290. PubMed ID: 31097680
[TBL] [Abstract][Full Text] [Related]
54. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
[TBL] [Abstract][Full Text] [Related]
55. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
[TBL] [Abstract][Full Text] [Related]
56. Heart Transplant Human Leukocyte Antigen Matching in the Modern Era.
Firoz A; Geier S; Yanagida R; Hamad E; Rakita V; Zhao H; Kashem M; Toyoda Y
J Card Fail; 2024 Feb; 30(2):362-372. PubMed ID: 37422273
[TBL] [Abstract][Full Text] [Related]
57. Human leukocyte antigens DR and AB and kidney retransplantation.
Thompson JS; Thacker LR; Krishnan G
Transplantation; 2003 Mar; 75(5):718-23. PubMed ID: 12640315
[TBL] [Abstract][Full Text] [Related]
58. Pancreas transplantation in the United States as reported to the United Network for Organ Sharing (UNOS) and analyzed by the International Pancreas Transplant Registry.
Sutherland DE; Gruessner A
Clin Transpl; 1995; ():49-67. PubMed ID: 8794254
[TBL] [Abstract][Full Text] [Related]
59. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
[TBL] [Abstract][Full Text] [Related]
60. [HLA compatibility and antigenic re-exposure. Impact on the clinical course of cadaver kidney transplantation].
Fernández Aparicio T; Miñana López B; Polo Villar G; Diaz González R; Fraile Gómez B; Aguirre Benites F; Morales Cerdán JM; Leiva Galvis O
Arch Esp Urol; 2000; 53(1):53-64. PubMed ID: 10730425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
